Quick Answer
Peppermint Oil Digestive Comfort Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: • Aromatherapy with lavender and lavender-peppermint essential oil impregnated into an absorbent pad and worn on the shoulder for 20 minutes before breast biopsy reduced anxiety and pain levels in women.
Key Takeaways
- 01• Aromatherapy with lavender and lavender-peppermint essential oil impregnated into an absorbent pad and worn on the shoulder for 20 minutes before breast biopsy reduced anxiety and pain levels in women. [Hancı Ezgi (2025)]
- 02• A positive correlation was found between pain and state anxiety levels, indicating that managing one may help alleviate the other. [Hancı Ezgi (2025)]
- 03• Aromatherapy provided a simple, cost-effective, and non-invasive nursing intervention that improved reported patient comfort before an interventional procedure. [Hancı Ezgi (2025)]
- 04Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. [Teterovska R (2025)]
The current Migaku evidence database contains 2 reusable source documents for Peppermint Oil Digestive Comfort Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- • Aromatherapy with lavender and lavender-peppermint essential oil impregnated into an absorbent pad and worn on the shoulder for 20 minutes before breast biopsy reduced anxiety and pain levels in women. [Hancı Ezgi (2025); evidence level 2]
- • A positive correlation was found between pain and state anxiety levels, indicating that managing one may help alleviate the other. [Hancı Ezgi (2025); evidence level 2]
- • Aromatherapy provided a simple, cost-effective, and non-invasive nursing intervention that improved reported patient comfort before an interventional procedure. [Hancı Ezgi (2025); evidence level 2]
- Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. [Teterovska R (2025); evidence level 4]
- Discrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges. [Teterovska R (2025); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources